Published in Diabetes Care on October 01, 1992
Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset. Diabetes Care (2009) 1.20
Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents. Eur J Pediatr (2006) 1.11
Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing. J Pediatr (2007) 1.06
An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission. Arch Dis Child Fetal Neonatal Ed (2004) 1.01
Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis. Diabetes Care (2012) 0.96
Metabolic tests to determine risk for type 1 diabetes in clinical trials. Diabetes Metab Res Rev (2011) 0.89
Strategies for preventing type I diabetes mellitus. West J Med (1996) 0.83
Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study. J Clin Immunol (2012) 0.78
Following the fate of the failing β-cell: new insights from first-phase insulin responses. Diabetes (2013) 0.78
First phase insulin release and glucose tolerance in children with Fanconi anemia after hematopoietic cell transplantation. Pediatr Blood Cancer (2009) 0.78
Standardization of IVGTT. Importance of method used to calculate glucose disappearance. Diabetes Care (1993) 0.78
Reduced β-cell function in early preclinical type 1 diabetes. Eur J Endocrinol (2015) 0.77
Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth. Diabetes Technol Ther (2013) 0.76
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet (2001) 6.14
Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med (1986) 6.11
Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes (1993) 5.70
Self-monitoring of blood-glucose. Improvement of diabetic control. Lancet (1978) 5.03
Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes (1996) 4.20
Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature (1998) 4.10
Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci U S A (1979) 4.09
Effect of improved glycemic control on health care costs and utilization. JAMA (2001) 3.91
Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A (2000) 3.89
The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet (1997) 3.70
Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY) JAMA (1996) 3.52
Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol (1990) 3.35
Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia (1996) 3.23
Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care (1999) 3.16
The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science (1986) 3.09
Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol (1981) 3.02
Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors. Science (1993) 2.94
DNA polymorphic haplotypes on the short arm of chromosome 11 and the inheritance of type I diabetes mellitus. J Med Genet (1986) 2.86
Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab (1996) 2.78
Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes (1997) 2.65
Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet (1993) 2.63
The prevalence of diabetic impotence. Diabetologia (1980) 2.47
Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics. Lancet (1979) 2.42
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes (1998) 2.38
Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation. J Immunol (1981) 2.30
Children with type-1 diabetes and their unaffected siblings have fewer symptoms of asthma. Lancet (1999) 2.26
Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets. Proc Natl Acad Sci U S A (1979) 2.07
Should surgeons treat diabetes in severely obese people? Lancet (2001) 2.05
Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia (2010) 2.04
Pre-pregnancy and pregnancy-related factors and the risk of excessive or inadequate gestational weight gain. Int J Gynaecol Obstet (2005) 2.00
Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. N Engl J Med (1983) 2.00
Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study. Lancet (1992) 2.00
Rising incidence of IDDM in Europe. Diabetes Care (1989) 1.94
Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? Br Med J (Clin Res Ed) (1982) 1.91
A novel micro-assay for insulin autoantibodies. J Autoimmun (1997) 1.90
Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. N Engl J Med (1982) 1.89
Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes (1994) 1.82
Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans. Proc Natl Acad Sci U S A (1980) 1.81
Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI. Eur J Biochem (1974) 1.76
Production of monoclonal antibodies reacting with peripheral blood mononuclear cell surface differentiation antigens. J Immunol (1980) 1.75
Predicting insulin-dependent diabetes. Lancet (1988) 1.75
Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes (1987) 1.72
64,000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet (1990) 1.70
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med (1983) 1.68
Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun (1996) 1.68
One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J Autoimmun (1999) 1.62
Congenital pancreatic hypoplasia: a syndrome of exocrine and endocrine pancreatic insufficiency. J Pediatr (1986) 1.59
Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure. N Engl J Med (1985) 1.57
A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J Exp Med (1988) 1.55
Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes. Diabetes (1995) 1.55
The BB diabetic rat. Profound T-cell lymphocytopenia. Diabetes (1981) 1.55
Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet (1990) 1.54
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2010) 1.53
Maturity-onset diabetes of youth in black Americans. N Engl J Med (1987) 1.53
Size dependence during the development of the amphibian foot. Colchicine-induced digital loss and reduction. J Embryol Exp Morphol (1983) 1.53
Sprouty proteins: modified modulators, matchmakers or missing links? J Endocrinol (2009) 1.52
ICA512 autoantibody radioassay. Diabetes (1995) 1.52
Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer (2005) 1.52
Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia (2001) 1.49
Incidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6. BMJ (1989) 1.49
T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc Natl Acad Sci U S A (1997) 1.49
First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. N Engl J Med (1985) 1.48
Polyclonal nature of islet cell antibodies in insulin-dependent diabetes. Autoimmunity (1988) 1.48
Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. Diabetes Res (1985) 1.48
Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care (1999) 1.47
Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care (1999) 1.44
Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials. Diabetes Care (1999) 1.43
Absorption of isophane (NPH) insulin and its clinical implications. Br Med J (Clin Res Ed) (1982) 1.40
Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. Am J Epidemiol (1992) 1.40
Pre-endoscopic antibiotics for the prevention of bacterial endocarditis: do we use them appropriately? Am J Gastroenterol (1994) 1.40
Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse. J Autoimmun (2000) 1.40
Immunotherapy in pre-type 1 diabetes mellitus. Diabetologia (1990) 1.39
Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes. J Clin Endocrinol Metab (1991) 1.39
The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice. Diabetologia (1989) 1.38
Plasma T4 and T3 levels in naturally metamorphosing Eurycea bislineata (Amphibia; Plethodontidae). Gen Comp Endocrinol (1986) 1.37
HLA class II typing of whole genome amplified mouth swab DNA. Tissue Antigens (2000) 1.37
Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest (2001) 1.35
Forearm glucose uptake during the oral glucose tolerance test in normal subjects. Diabetes (1973) 1.34
Patient-level estimates of the cost of complications in diabetes in a managed-care population. Pharmacoeconomics (1999) 1.34
Type I (insulin dependent) diabetes: a disease of slow clinical onset? Br Med J (Clin Res Ed) (1987) 1.32
Transglutaminase antibodies in children with a genetic risk for celiac disease. J Pediatr (2000) 1.31
Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr (1981) 1.30
Presentation and progress of childhood diabetes mellitus: a prospective population-based study. The Bart's-Oxford Study Group. Diabetologia (1994) 1.30
Identification of human and rodent thymic epithelium using tetanus toxin and monoclonal antibody A2B5. J Clin Invest (1983) 1.29
Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses. J Exp Med (1984) 1.28
Assay for islet cell antibodies. Protein A--monoclonal antibody method. Diabetes (1985) 1.28
Expression of receptors for tetanus toxin and monoclonal antibody A2B5 by pancreatic islet cells. Proc Natl Acad Sci U S A (1982) 1.27
Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res (1986) 1.27